Macrophage‐derived insulin antagonist ImpL2 induces lipoprotein mobilization upon bacterial infection
The EMBO Journal · 2023
DOI: 10.15252/embj.2023114086 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von Gabriela Krejčová und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic. Hauptthemen laut MEDLINE: Bacterial Infections, Insulin Resistance, Drosophila Proteins. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Czech Science Foundation (GACR), USB Grant Agency.
Themen: Mobilisation
Abstract (Originalsprache)
The immune response is an energy-demanding process that must be coordinated with systemic metabolic changes redirecting nutrients from stores to the immune system. Although this interplay is fundamental for the function of the immune system, the underlying mechanisms remain elusive. Our data show that the pro-inflammatory polarization of Drosophila macrophages is coupled to the production of the insulin antagonist ImpL2 through the activity of the transcription factor HIF1α. ImpL2 production, reflecting nutritional demands of activated macrophages, subsequently impairs insulin signaling in the fat body, thereby triggering FOXO-driven mobilization of lipoproteins. This metabolic adaptation is fundamental for the function of the immune system and an individual's resistance to infection. We demonstrated that analogically to Drosophila, mammalian immune-activated macrophages produce ImpL2 homolog IGFBP7 in a HIF1α-dependent manner and that enhanced IGFBP7 production by these cells induces mobilization of lipoproteins from hepatocytes. Hence, the production of ImpL2/IGFBP7 by macrophages represents an evolutionarily conserved mechanism by which macrophages alleviate insulin signaling in the central metabolic organ to secure nutrients necessary for their function upon bacterial infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic.
- Department of Medicine, Integrated Cardio Metabolic Center (ICMC), Karolinska Institutet, Huddinge, Sweden.
- Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
- University of Tübingen, Tübingen, Germany.
- Biology Centre CAS, Institute of Parasitology, Ceske Budejovice, Czech Republic.
- Department of Experimental Plant Biology, Faculty of Science, University of South Bohemia, Ceske Budejovice, Czech Republic.
ORCID-Profile: Gabriela Krejčová, Julie Kovářová, Tomáš Doležal, Adam Bajgar
Förderung
- The Czech Science Foundation (GACR)
- USB Grant Agency
Zitieren
APA
Krejčová, G., Morgantini, C., Zemanová, H., Lauschke, V. M., Kovářová, J., Kubásek, J., Nedbalová, P., Kamps-Hughes, N., Moos, M., Aouadi, M., Doležal, T., & Bajgar, A. (2023). Macrophage‐derived insulin antagonist ImpL2 induces lipoprotein mobilization upon bacterial infection. The EMBO Journal. https://doi.org/10.15252/embj.2023114086
Vancouver
Krejčová G, Morgantini C, Zemanová H, Lauschke VM, Kovářová J, Kubásek J, et al. Macrophage‐derived insulin antagonist ImpL2 induces lipoprotein mobilization upon bacterial infection. The EMBO Journal. 2023. doi:10.15252/embj.2023114086
BibTeX
@article{Krejov2023,
author = {Krejčová, Gabriela and Morgantini, Cecilia and Zemanová, Helena and Lauschke, Volker M and Kovářová, Julie and Kubásek, Jiří and Nedbalová, Pavla and Kamps-Hughes, Nick and Moos, Martin and Aouadi, Myriam and Doležal, Tomáš and Bajgar, Adam},
title = {Macrophage‐derived insulin antagonist ImpL2 induces lipoprotein mobilization upon bacterial infection},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2023114086}
}
EUVIMED